Clinicopathological characteristics and molecular alterations of primary cardiac leiomyosarcoma: report of five cases
10.3760/cma.j.cn112151-20211026-00775
- VernacularTitle:原发性心脏平滑肌肉瘤5例临床病理学特点及分子改变
- Author:
Fang DONG
1
;
Dong CHEN
;
Jianfeng SHANG
;
Wei FANG
;
Liyuan HAN
;
Guoliang LIAN
;
Hao WANG
;
Menghan ZHENG
Author Information
1. 首都医科大学附属北京安贞医院病理科，北京 100029
- Keywords:
Heart neoplasms;
Leiomyosarcoma;
Molecular diagnostic techniques;
Prognosis
- From:
Chinese Journal of Pathology
2022;51(6):512-517
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical, pathologic and radiologic features and molecular alterations in patients with primary cardiac leiomyosarcoma (PCLMS).Methods:Five cases of PCLMS were collected in Beijing Anzhen Hospital from January 2016 to December 2020. The clinical, pathologic and radiologic data, and molecular alterations were analyzed, and the patients were followed up.Results:All five patients were female, and had no history of leiomyosarcoma in other parts of the body. The age of patients ranged from 37 to 62 years (median 47 years). The main clinical symptoms were chest pain and dyspnea, one also presented with palpitation and lower limb weakness and one with dizziness. Two tumors were located in the left atrium, two in the right atrium, and one in the right ventricle, and they maximal diameter ranged from 2.5 to 14.0 cm (mean 6.2 cm). The neoplasms presented as medium-echo masses with a broad base in the echocardiography, and as a low-density, solid mass when detected by contrast-enhanced CT. Histologically, two tumors were well-differentiated and three were moderately and poorly differentiated, and two included extensive, loose myxoid stroma. Immunohistochemical staining showed that PCLMS was positive for SMA, desmin, MDM2, and epidermal growth factor receptor. Fluorescence in situ hybridization showed ALK gene rearrangement in two cases, and COL1A1-PDGFB fusion in three cases. All cases received surgical excision and two cases received chemotherapy. Three patients died within 0-11 months (mean survival of 7.7 months) and two patients were alive.Conclusions:PCLMS is a malignant tumor with a high recurrence rate and poor prognosis. These cases may provide useful information to improve the diagnosis and management of PCLMS.
